Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Imaging and Radioligand Therapy
Open Access
- 27 July 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 21 (8) , 1883-1890
Abstract
Talazoparib (TZ) is a potent poly(ADP-ribose) polymerase 1/2 (PARP1/2) inhibitor that uniquely traps PARP complexes at sites of single-strand DNA damage thereby offering opportunities for targeted radioligand therapy. Radiolabeled halogenated TZ derivatives were synthesized using boronic ester precursors to enable incorporation of diagnostic and therapeutic radionuclides: 18F for PET imaging, 77Br for Auger electron radiotherapy, and 211At for targeted alpha radiotherapy. Copper-mediated radio-halogenation afforded racemic 18F-TZ, 77Br-TZ, and 211At-TZ in sufficient radiochemical yields (4.3 ± 2.6%, n = 33; 29.0 ± 12.0%, n = 4; 3.6 ± 3.8%, n = 9, respectively), ∼99% radiochemical purity and proven stability under formulation conditions. Molecular dynamics simulations of halo-TZ derivatives predicted an inverse relationship between halogen size and PARP1 binding affinity. Indeed, cell uptake of radio-halogenated TZ analogues indicated selective uptake in a panel of cell types that correlated with PARP1 levels but was inversely related to the atomic radii of the halogen series. Despite modest specific activity and specific uptake, 77Br-TZ showed significant cytotoxicity. Further investigation of 18F-TZ with 77Br-TZ as a radiotheranostic pair will be facilitated by the synthetic schemes herein.Keywords
Funding Information
- U.S. Department of Energy (DE-FG02-93ER4077)
- U.S. Department of Energy (DE-SC0020958)
- U.S. Department of Energy (DE-SC0024600)
- National Cancer Institute (5R01CA273130)
- University of Texas MD Anderson Cancer Center (NA)
This publication has 46 references indexed in Scilit:
- A Design of Experiments‐Based Chiral HPLC Method for the Quantification of Talazoparib and Enantiomeric Purity Determination in Pharmaceutical FormulationsChirality, 2026
- Combinations of treatments based on radiotherapy or radionuclides to enhance immunotherapy efficacy in advanced prostate cancer: a systematic reviewJournal of Cancer Research and Clinical Oncology, 2025
- In Vitro and Preclinical Systematic Dose-Effect Studies of Auger Electron- and β Particle-Emitting Radionuclides and External Beam Radiation for Cancer TreatmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2024
- PARP trapping is governed by the PARP inhibitor dissociation rate constantCell Chemical Biology, 2024
- Base‐Mediated Radio‐Iodination of Arenes by Using Organosilane and Organogermane as Radiolabelling PrecursorsChemistry – A European Journal, 2023
- 18F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomographyEuropean Journal of Medicinal Chemistry, 2020
- Evaluation of aromatic radiobromination by nucleophilic substitution using diaryliodonium salt precursorsJournal of Labelled Compounds and Radiopharmaceuticals, 2017
- Production of 211 At by a vertical beam irradiation methodApplied Radiation and Isotopes, 2014
- A General Copper‐Mediated Nucleophilic 18F Fluorination of ArenesAngewandte Chemie International Edition, 2014
- Intracellular water‐specific MR of microbead‐adherent cells: the HeLa cell intracellular water exchange lifetimeNMR in Biomedicine, 2008